Background

The International Trade Commission has recently announced the following actions in intellectual property rights infringement investigations. For more information on pursuing or mitigating IPR-related import restrictions, please contact attorney Lee Sandler via email or at (305) 894-1000.

Audio players – institution of patent infringement investigation 337-TA-1329 of audio players and components thereof (complainant Google LLC; respondent located in U.S.)

Power inverters – initial determination of violation in investigation 337-TA-1267 of power inverters and converters, vehicles containing the same, and components thereof and recommendation to issue a limited exclusion order and cease and desist orders

rHSA – in investigation 337-TA-1238 (1) issuance of (a) limited exclusion orders prohibiting the unlicensed entry of infringing plant-derived recombinant human serum albumins and products containing same that (1) are covered by certain patent claims or (b) include a false designation of origin and that are manufactured or imported by or on behalf of the respondents, and (2) cease and desist orders directed against the respondents (these orders also apply to any of the respondents’ affiliated companies, parents, subsidiaries, or other related business entities or their successors or assigns)

Storage systems – new IPR infringement complaint filed on automated put walls and automated storage and retrieval systems, associated vehicles, associated control software, and component parts thereof (complainant OPEX Corporation; proposed respondents located in China and U.S.)

Copyright © 2022 Sandler, Travis & Rosenberg, P.A.; WorldTrade Interactive, Inc. All rights reserved.

ST&R: International Trade Law & Policy

Since 1977, we have set the standard for international trade lawyers and consultants, providing comprehensive and effective customs, import and export services to clients worldwide.

View Our Services 

Close

Cookie Consent

We have updated our Privacy Policy relating to our use of cookies on our website and the sharing of information. By continuing to use our website or subscribe to our publications, you agree to the Privacy Policy and Terms & Conditions.